Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 50 of 421 publications.

Ueda K, Takura T, Fujikoshi S, Meyers J, Nagar SP, Enomoto H. Long-term pain management and health care resource use among an employed population in Japan with knee osteoarthritis combined with low back pain. Pain Med. 2020 Dec 30;pnaa424. doi: 10.1093/pm/pnaa424

Njue A, Coyne C, Margulis AV, Wang D, Marks MA, Russell K, Das R, Sinha A. The role of congenital cytomegalovirus infection in adverse birth outcomes: a review of the potential mechanisms. Viruses. 2020 Dec 24;13(1):E20. doi: 10.3390/v13010020

Hendrix N, Hauber B, Lee CI, Bansal A, Veenstra DL. Artificial intelligence in breast cancer screening: primary care provider preferences. JAMIA. 2020 Dec 23. doi: 10.1093/jamia/ocaa292

Doward LC, Balp M-M, Twiss J, Slota C, Cryer D, Brass CA, Anstee QM, Sanyal AJ. Development of a patient-reported outcome measure for non-alcoholic steatohepatitis (NASH-CHECK): results of a qualitative study. Patient. 2020 Dec 18. doi: 10.1007/s40271-020-00485-w

Davidson D, Hsieh A, Vera-Llonch M, Stevenson M, Brown TM, Slota CM, Fehnel SE. Development of a novel patient-reported outcome measure for symptoms and impacts of familial chylomicronemia syndrome. Poster presented at the 2020 Virtual National Lipid Association Scientific Sessions; December 10, 2020.

Layton JB, Li W, Yuan J, Gilman JP, Horton DB, Setoguchi S. Heatwaves, medications, and heat-related hospitalization in older Medicare beneficiaries with chronic conditions. PLoS One. 2020 Dec 10;15(12):e0243665. doi: 10.1371/journal.pone.0243665

Anderson S, Carrico J, Brodtkorb T-H, Lalla D, Brufsky A. Budget impact of introducing neratinib for third-line treatment of HER2+ metastatic breast cancer in the United States. Poster presented at the 2020 Virtual San Antonio Breast Cancer (SABCS) Meeting; December 9, 2020.

Brodtkorb TH, McDade C, Lalla D, Holmes FA. Cost-effectiveness of neratinib for the extended adjuvant treatment of adult patients with early-stage, HR+, HER2-overexpressed/amplified breast cancer who initiated neratinib within 1 year of completing trastuzumab in the US. Poster presented at the 2020 Virtual San Antonio Breast Cancer Symposium (SABCS); December 9, 2020.

Heyes AE, Nuabor WA, Costello JJ, Mauskopf JM, Petitiean A, Andrew MK. Posthospitalisation outcomes in older patients hospitalised for influenza: a comprehensive literature review. Poster presented at the 2020 Virtual 7th ESWI Influenza Conference; December 6, 2020.

Rosenow F, Winter Y, Leunikava I, Brunnert M, Sutphin J, Boeri M, Villani F, Brandt C. Patient and physician preferences in epilepsy monotherapy in a real world study (VOTE): evidence from discrete choice experiments. Poster presented at the 2020 Virtual 74th American Epilepsy Society (AES) Annual Meeting; December 4, 2020.

Orji CC, Kanu C, Adelodun AI, Brown CM. Factors that influence mammography use for breast cancer screening among African American women. J Natl Med Assoc. 2020 Dec;112(6):578-92. doi: 10.1016/j.jnma.2020.05.004

Aronsson M, Dunton K, Hawe E, Wolowacz S, Quoraishi S, Durrington P, Ray KK, Bilitou A. Building a cost-effectiveness MODEL framework from a payer's perspective to assess NOVEL treatments in primary hypercholesterolaemia and MIXED dyslipidaemia: challenges in a world of LDL-C lowering. Poster presented at the Virtual ISPOR Europe 2020 Conference; November 2020. [abstract] Value Health. 2020 Dec; 23(S2).

Dorgali MV, Longo A, Vass C, Shields G, Harrison R, Boeri M. Exploring Antimicrobial Resistance (AMR) from a societal perspective: preferences and welfare impacts in the United Kingdom. Poster presented at the Virtual ISPOR Europe 2020 Conference; November 2020. [abstract] Value Health. 2020 Dec; 23(S2).

Howard SJ, Elvey R, Ohrnberger J, Turner AJ, Anselmi L, Martindale A-M, Blakeman T. Post-discharge care following acute kidney injury: quality improvement in primary care. BMJ Open Qual. 2020 Dec;9(4):e000891. doi: 10.1136/bmjoq-2019-000891

D'Souza VK, Alderson D. Early access and targeted supply considerations in emerging markets. Poster presented at the Virtual 2020 ISPOR Europe; November 16, 2020. [abstract] Value Health. 2020 Dec; 23(S2):S656. doi: 10.1016/j.jval.2020.08.1524

Turner AJ, Vass C. Matching techniques in stated preferences for health. Presented at the Virtual ISPOR Europe 2020 Conference; November 9, 2020. [abstract] Value Health. 2020 Dec; 23(Supplement 2):S758. doi: 10.1016/j.jval.2020.08.2086

Turner AJ, Anselmi L, Lau YS, Sutton M. The effects of unexpected changes in demand on the performance of emergency departments. Health Econ. 2020 Dec;29(12):1744-63. doi: 10.1002/hec.4167

Stevenson A, Gildea L. A Medtech roadmap: new routes to market access in the UK NHS. Poster presented at the Virtual ISPOR Europe 2020 Conference; November 2020. [abstract] Value Health. 2020 Dec; 23(S2):S576.

Vass C, Rigby D, Payne K. Watching ME watching you: understanding the effect of experimental setting on stated preferences. Poster presented at the Virtual ISPOR Europe 2020 Conference; November 2020. [abstract] Value Health. 2020 Dec; 23(S2).

Cohen JL, Sadick NS, Kirby MT, McLane MP, Lenderking WR, Bender RH, Chen J, Hurley D, Knoble NB, Liu G, Xiang Q, Davidson JA, Goldman MP. Development and validation clinician and patient reported photonumeric scales to assess buttocks cellulite severity. Dermatol Surg. 2020 Dec;46(12):1628-35. doi: 10.1097/DSS.0000000000002756

Noon K, Costello J, Krieger T, Rothwell B, Pearson I. Utility weight considerations in NICE immune checkpoint inhibitor oncology appraisals. Poster presented at the Virtual ISPOR Europe 2020 Conference; November 2020. [abstract] Value Health. 2020 Dec; 23(S2).

Atkins R, Turner AJ, Chandola T, Sutton M. Going beyond the mean in examining relationships of adolescent non-cognitive skills with health-related quality of life and biomarkers in later-life. Econ Hum Biol. 2020 Dec;39:100923. doi: 10.1016/j.ehb.2020.100923

Carrico J, La EM, Talbird SE, Chen YT, Nyaku MK, Carias C, Marshall GS, Roberts CS. Economic impact of routine childhood immunization in the 2017 United States birth cohort. Presented at the Virtual ISPOR Europe 2020 Conference; November 2020. [abstract] Value Health. 2020 Dec 1; 23(Supplement 2):S427. doi: 10.1016/j.jval.2020.08.039

Singh P, Contente M, Shillington A, Dave V, Kiff C, Cotte FE, Macahilig C. Treatment and outcomes in recurrent metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): a chart review study in France, Germany and the United Kingdom. Poster presented at the Virtual ISPOR 2020 Conference; November 2020. [abstract] Value Health. 2020 Dec 1; 23(Supplement 2):S427. doi: 10.1016/j.jval.2020.08.172

Bektas M, Copley-Merriman C, Khan S, Sarda SP, Shammo JM. Paroxysmal nocturnal hemoglobinuria: patient journey and burden of disease. J Manag Care Spec Pharm. 2020 Dec;26(12-b Suppl):S8-S14. doi: 10.18553/jmcp.2020.26.12-b.s8

Bektas M, Copley-Merriman C, Khan S, Sarda SP, Shammo JM. Paroxysmal nocturnal hemoglobinuria: role of the complement system, pathogenesis, and pathophysiology. J Manag Care Spec Pharm. 2020 Dec;26(12-b Suppl):S3-8. doi: 10.18553/jmcp.2020.26.12-b.s3

Bektas M, Copley-Merriman C, Khan S, Sarda SP, Shammo JM. Paroxysmal nocturnal hemoglobinuria: current treatments and unmet needs. J Manag Care Spec Pharm. 2020 Dec;26(12-b Suppl):S14-20. doi: 10.18553/jmcp.2020.26.12-b.s14

Lash TL, VanderWeele TJ, Haneuse S, Rothman KJ. Modern epidemiology. 4th ed. Philadelphia: PA. Wolters Klouwer; 2020.

Shah SN, Hepp Z, Martin S, Harris N, Morgans A. Qualitative analysis of pain in patients with locally advanced or metastatic urothelial cancer. Poster presented at the Virtual ISPOR Europe 2020 Conference; November 2020. [abstract] Value Health. 2020 Dec; 23(S2).

Gilsenan A, Midkiff K, Harris D, McQuay L, Hunter S, Kellier-Steele N, Andrews E. Assessing the incidence of osteosarcoma among teriparatide users based on Medicare Part D and US State Cancer Registry Data. Pharmacoepidemiol Drug Saf. 2020 Dec;29(12):1616-26. doi: 10.1002/pds.5103

Ervin CM, Whalley D, von Huth Smith L, Crawford R, Dine J, Fehnel SE. Development of the impact of weight on daily activities questionnaire: a patient-reported outcome measure. Clin Obes. 2020 Dec;10(6):e12387. doi: 10.1111/cob.12387

Herring W, Gould I, Haines P, Thompson R, Pemberton-Ross P. Predicted delays in dementia onset for an innovative therapy acting on beta-amyloid in patients with mild cognitive impairment due to Alzheimer's disease. Poster presented at the Virtual ISPOR Europe 2020 Conference; November 16, 2020. [abstract] Value Health. 2020 Dec; 23(S2).

van Overbeeke E, Hauber B, Michelsen S, Peerlinck K, Lambert C, Hermans C, Le PQ, Goldman M, Simoens S, Huys I. Patient preferences for gene therapy in hemophilia: results from the paving threshold technique survey. Poster presented at the Virtual ISPOR Europe 2020 Conference; November 2020. [abstract] Value Health. 2020 Dec; 23(S2).

Purser M, Gallagher M, Mladsi D, Weber JM, Andemariam B, Kaye JA, Chawla A. Evaluation of published models in sickle cell disease against key criteria for an economic model for a potentially curative one-time treatment. Poster presented at the Virtual ISPOR Europe 2020 Conference; November 2020. [abstract] Value Health. 2020 Dec; 23(S2). doi: 10.1016/j.jval.2020.08.098

Ali MS, Berencsi K, Marinier K, Deltour N, Perez-Gutthann S, Pedersen L, Rijnbeek P, Lapi F, Simonetti M, Reyes C, Van Der Lei J, Sturkenboom M, Prieto-Alhambra D. Comparative cardiovascular safety of strontium ranelate and bisphosphonates: a multi-database study in 5 EU countries by the EU-ADR Alliance. Osteoporos Int. 2020 Dec;31(12):2425-38.

Patterson BJ, Herring WL, Van Oorschot D, Curran D, Carrico J, Zhang Y, Ackerson BK, Bruxvoort K, Sy LS, Tseng HF. Incremental clinical and economic impact of recombinant zoster vaccination: real-world data in a budget impact model. J Manag Care Spec Pharm. 2020 Dec;26(12):1567-75. doi: 10.18553/jmcp.2020.20251

Manga N. Applying a normal distribution to costs in probabilistic sensitivity analysis - NOT necessarily a negative outcome. Poster presented at the Virtual ISPOR Europe 2020 Conference; November 2020. [abstract] Value Health. 2020 Dec; 23(S2).

Fastenau J, Rozjabek H, Qin S, McLeod L, Nelson L, Ma J, Harris N. Psychometric evaluation of the DAILY EATS questionnaire in individuals living with obesity. J Patient Rep Outcomes. 2020 Nov 23;4(1):99. doi: 10.1186/s41687-020-00259-w

Kvien TK, Conaghan PG, Gossec L, Strand V, Ostergaard M, Poddubnyy D, Williams N, Porter B, Shete A, Gilloteau I, Deodhar A. Secukinumab provides sustained reduction in fatigue in patients with ankylosing spondylitis: long-term results of two phase III randomized controlled trials. Arthritis Care Res (Hoboken). 2020 Nov 23. doi: 10.1002/acr.24517

Obeid E, Parikh R, Esterberg E, Arondekar B, Hitchens A, Shahied Arruda L, Niyazov A. Genetic Counseling (GC) patterns by practice setting among patients (pts) with germline BRCA1/2 mutated (gBRCA1/2mut) Advanced Breast Cancer (ABC): results from a US retrospective medical records review study. Poster presented at the 2020 Virtual NSGC 39th Annual Conference; November 18, 2020.

Hoffman V, Hallas J, Linder M, Margulis A, Suehs BT, Arana A, Enger C, Horter L, Odsbu I, Olesen M, Perez-Gutthann S, Xu Y, Kristiansen NS, Appenteng K, de Vogel S, Seeger JD. Cardiovascular risk in users of mirabegron relative to users of antimuscarinic treatments for overactive bladder: findings from a non-interventional, real-world data safety study. Poster presented at the 2020 Virtual American Heart Association’s Scientific Sessions; November 13, 2020.

Yland JJ, Bresnick KA, Hatch EE, Wesselink AK, Mikkelsen EM, Rothman KJ, Sorensen HT, Huybrechts KF, Wise LA. Pregravid contraceptive use and fecundability: prospective cohort study. BMJ. 2020 Nov 11;371:m3966. doi: 10.1136/bmj.m3966

Wesselink AK, Kirwa K, Hatch EE, Hystad P, Szpiro AA, Kaufman JD, Levy JI, Mikkelsen EM, Quraishi SM, Rothman KJ, Wise LA. Residential proximity to major roads and fecundability in a preconception cohort. Environ Epidemiol. 2020 Nov 11;4(6):e112. doi: 10.1097/EE9.0000000000000112

Rudell K, Doward L, Bennett B, Rodriguez AM, Jane Rylands AJ. Expanding COA in 2020 – guidance in RWE and improving communication between different stakeholders. Presented at the Virtual ISPOR Europe 2020 Conference; November 11, 2020.

Vass CM, de Bekker-Grob E, Shields G, Abraham L. Who is the ‘patient' in patient preference studies? Current practice and future challenges. Presented at the Virtual ISPOR Europe 2020 Conference; November 9, 2020.

van Overbeeke E, Michelsen S, Hauber B, Peerlinck K, Hermans C, Lambert C, Goldman M, Simoens S, Huys I. Patient perspectives regarding gene therapy in haemophilia: interviews from the PAVING study. Haemophilia. 2020 Nov 7. doi: 10.1111/hae.14190

Dzimitrowicz H, Esterberg L, Miles L, Zanotti G, Borham A, Harrison MR. Real-world referral and adjuvant treatment patterns in high-risk locoregional renal cell carcinoma. Poster presented at the 2020 Virtual International Kidney Virtual Cancer (IKCS) Symposium; November 6, 2020.

Sun SX, Olayinka-Amao O, DiBenedetti D. Assessing patient experiences with prophylactic treatments for hemophilia A: concept elicitation for gene therapy. Poster presented at the 62nd Annual Virtual Meeting of the American Society of Hematology (ASH); December 5, 2020. [abstract] Blood. 2020 Nov 5; 136(Suppl 1):33-4.

Spira AI, Chen L, Zhou X, Gnanasakthy A, Wang L, Ungar D, Curiel R, Radford JA, Kahl BS. Symptoms, health-related quality of life, and tolerability of loncastuximab tesirine in patients with relapsed or refractory diffuse large b cell lymphoma. Blood. 2020 Nov 5;136(Suppl 1):3-4. doi: 10.1182/blood-2020-139571

Gilsenan A, Harris D, Reynolds M, McSorley D, Midkiff K, Jackson L, Muldavin B, Kellier-Steele N, Andrews E. Long-term cancer surveillance: results from the Forteo Patient Registry Surveillance Study. Osteoporos Int. 2020 Nov 5;32(4):645-51. doi: 10.1007/s00198-020-05718-0